Quantification of the degradation products of sevoflurane using four brands of CO2 absorbent in a standard anesthetic circuit

Journal of Anesthesia

Volumn 14, Issue 3, 2000, Pages 143-146

  Ikeuchi, Y ^a   Bito, H ^a   Katoh, T ^a   Sato, S ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anesthetic system; Anesthetics; CO2 absorbent; Compound A; Low flow anesthesia; Sevoflurane; Volatile

Indexed keywords

2,2 DIFLUORO 1 (TRIFLUOROMETHYL)VINYL FLUOROMETHYL ETHER; ALUMINUM HYDROXIDE; BARIUM DERIVATIVE; CALCIUM HYDROXIDE; CARBON DIOXIDE; DRUG METABOLITE; MAGNESIUM HYDROXIDE; POTASSIUM HYDROXIDE; SEVOFLURANE; SILICATE; SODIUM HYDROXIDE; SORBENT; WATER;

ABSORPTION; ANALYTIC METHOD; ANESTHESIA; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG DEGRADATION; FLOW RATE; MODEL; TEMPERATURE MEASUREMENT;

EID: 0033859352     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005400070022     Document Type: Article

References (25)

1. Sevoflurane: A new inhalational anesthetic agent
2. Reaction of sevoflurane and its degradation products with soda lime: Toxicity of the byproducts
3. Toxicity of compound A in rats: Effect of a 3-hour administration
4. Toxicity of compound A in rats: Effect of increasing duration of administration
5. Nephrotoxicity in rats undergoing a one-hour exposure to compound A
6. Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats
7. Effect of total flow rate on the concentration of degradation products generated by reaction between sevoflurane and soda lime
8. Factors affecting the concentration of compound A resulting from the degradation of sevoflurane by soda lime and Baralyme® in a standard anesthetic circuit
9. Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents: Quantification of degradation products in the circuit
10. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme® and soda lime
11. Sevoflurane degradation by soda lime in a circle breathing system
12. Inhibition of volatile sevoflurane degradation product formation in an anesthesia circuit by a reduction in soda lime temperature
13. Sevoflurane degradation to compound A in anaesthesia breathing systems
14. Reaction products of sevoflurane with new Sodalime-A under various conditions (in Japanese with English abstract)
15. Absorption and degradation of sevoflurane and isoflurane in a conventional anesthetic circuit
16. 2 absorbents during low-flow anesthesia in surgical patients
17. 2 absorbents during low-flow sevoflurane anesthesia in surgical patients
18. Factors affecting the rate of disappearance of sevoflurane in Baralyme
19. Effects of water content of soda lime on compound A concentration in the anesthesia circuit in sevoflurane anesthesia
20. The degradation, absorption, and solubility of volatile anesthetics in soda lime depend on water content
21. Dehydration of Baralyme® increases compound A resulting from sevoflurane degradation in a standard anesthetic circuit used to anesthetize swine
22. Stability of sevoflurane in soda lime
23. Reaction products of sevoflurane with components of soda lime under various conditions (in Japanese with English abstract)
24. Plasma inorganic fluoride and intracircuit degradation product concentrations in long-duration, low-flow sevoflurane anesthesia
25. Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia